200 related articles for article (PubMed ID: 36966271)
21. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
22. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
23. Impact of contrast-enhanced mammography in surgical management of breast cancers for women with dense breasts: a dual-center, multi-disciplinary study in Asia.
Goh Y; Chou CP; Chan CW; Buhari SA; Hartman M; Tang SW; Ng CWQ; Pillay P; Chua W; Jagmohan P; Sterling E; Wong YM; Tan LY; Ong HY; Pan HB; Lee HS; Hung BH; Quek ST
Eur Radiol; 2022 Dec; 32(12):8226-8237. PubMed ID: 35788756
[TBL] [Abstract][Full Text] [Related]
24. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
25. MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.
Nadler M; Al-Attar H; Warner E; Martel AL; Balasingham S; Zhang L; Lipton JH; Curpen B
Breast; 2017 Aug; 34():77-82. PubMed ID: 28527397
[TBL] [Abstract][Full Text] [Related]
26. Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.
Åhsberg K; Gardfjell A; Nimeus E; Rasmussen R; Behmer C; Zackrisson S; Ryden L
World J Surg Oncol; 2020 May; 18(1):100. PubMed ID: 32438917
[TBL] [Abstract][Full Text] [Related]
27. What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?
Sardanelli F; Bacigalupo L; Carbonaro L; Esseridou A; Giuseppetti GM; Panizza P; Lattanzio V; Del Maschio A
Radiol Med; 2008 Apr; 113(3):439-51. PubMed ID: 18414812
[TBL] [Abstract][Full Text] [Related]
28. Breast masses with rim enhancement on contrast-enhanced mammography: morphological and enhancement features for diagnosis and differentiation of benign and malignant.
Wen C; Wang S; Ma M; Xu Z; Zeng F; Zeng H; Liao X; He Z; Xu W; Chen W
Br J Radiol; 2024 May; 97(1157):1016-1021. PubMed ID: 38521539
[TBL] [Abstract][Full Text] [Related]
29. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
Kim JS; Lee SM; Cha ES
Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
[TBL] [Abstract][Full Text] [Related]
31. Patient preferences regarding use of contrast-enhanced imaging for breast cancer screening.
Son D; Phillips J; Mehta TS; Mehta R; Brook A; Dialani VM
Acad Radiol; 2022 Jan; 29 Suppl 1():S229-S238. PubMed ID: 33846061
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Evaluation of Recalled Noncalcified Lesions Using Ultrasound Alone Versus Ultrasound Plus Additional Mammographic Views: A Prospective Study.
Porembka JH; Seiler SJ; Sharifi A; Mootz AR; Knippa E; Evans WP; Chen H; Xi Y; Dogan BE
AJR Am J Roentgenol; 2022 Jun; 218(6):977-987. PubMed ID: 34910533
[No Abstract] [Full Text] [Related]
33. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
[TBL] [Abstract][Full Text] [Related]
34. BreastScreen-based mammography screening in women with a personal history of breast cancer, Western Australian study.
Houssami N; Tresham JJ; Fritschi L; Wylie LE
Med J Aust; 2011 Oct; 195(8):460-4. PubMed ID: 22004397
[TBL] [Abstract][Full Text] [Related]
35. Choice of imaging method in the work-up of non-calcified breast lesions identified on tomosynthesis screening.
Porembka JH; Baydoun S; Mootz AR; Xi Y; Dogan BE
Eur J Radiol; 2020 Oct; 131():109203. PubMed ID: 32771916
[TBL] [Abstract][Full Text] [Related]
36. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
[TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performances of supplemental breast ultrasound screening in women with personal history of breast cancer.
Song SE; Cho N; Chang JM; Chu AJ; Yi A; Moon WK
Acta Radiol; 2018 May; 59(5):533-539. PubMed ID: 28786298
[TBL] [Abstract][Full Text] [Related]
40. Failure of stereotactic core needle biopsy in women recalled for suspicious calcifications at screening mammography: frequency, causes, and final outcome in a multi-institutional, observational follow-up study.
Duijm LEM; Strobbe LJA; van Breest Smallenburg V; Vreuls W; Boerman T; van Beek HC; Op de Coul-Froger CL; Setz-Pels W; Voogd AC
Eur Radiol; 2022 Nov; 32(11):7420-7429. PubMed ID: 35486173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
